ANI Pharmaceuticals SVP Ori Gutwerg Sells 2,772 Shares at $79.50

This Form 4 filing reports that Ori Gutwerg, Senior Vice President of Generics at ANI Pharmaceuticals Inc., sold 2,772 shares of common stock on May 12, 2026, at a price of $79.50 per share. Following this transaction, Gutwerg's remaining ownership position stands at 78,696 shares. The filing indicates this was a direct ownership transaction (code "D") and the sale was executed under transaction code "S." The filing was signed by attorney-in-fact Meredith W. Cook on behalf of Gutwerg on May 13, 2026. This represents a routine insider transaction by a corporate officer, which is common for executives to manage their personal financial positions while maintaining significant ownership in the company.